Ken Griffin Age X Therapeutics, Inc. Call Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AGE
# of Institutions
1Shares Held
1KCall Options Held
0Put Options Held
0About AgeX Therapeutics, Inc.
- Ticker AGE
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,945,100
- Description
- AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...